Grade My Investments
Home › Free Stock Grades › ATRC

AtriCure, Inc. (ATRC) Stock Grade

ATRC · Healthcare

C
Grade updated: September 29, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$3.0B
P/E Ratio
326.5
Revenue Growth (YoY)
+14.9%
Net Margin
-2.1%
Return on Equity
—
Dividend Yield
None

About AtriCure, Inc.'s fundamentals

AtriCure is a $3.0 billion healthcare company in the medical devices sector that is growing revenue at a solid 14.9% year-over-year pace. However, the company is currently unprofitable with a negative 2.1% net margin and reported a net loss in its latest annual statement, though it is generating positive free cash flow despite these accounting losses. The stock's P/E ratio of 326.5 reflects the market's pricing of a currently loss-making business. The company does not pay a dividend.

Track ATRC free — no credit card required. Live grade + monthly AI report →